Danazol
Active substance: danazol
CAPSULE · DANAZOL 50 mg/1
United StatesActive
Marketing holder: Teva Pharmaceuticals USA, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- DANAZOL · 50 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c4-d9d4-75fa-89fe-c1f3f1bf55bf;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2ebc-71af-a731-e75241572b1d,01a1208c-8837-798b-9f04-29fb1c448ca5,01a1208d-bf90-744c-ac71-8cd326fcc70e,01a12090-e026-733b-bcb2-f8ece33e1f60,01a12093-fc8b-73aa-9ed7-19575fadd5c4;count=11 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0555-0633
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0555-0633 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0555-0633 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0555-0633 · Verified 2026-10-09 · open in source